Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 05:00 ET | Source: Helsinn Healthcare S.A.

Helsinn announces European Commission approval of AKYNZEO® Oral Suspension

Lugano, Switzerland – February 18th, 2026 – Helsinn Healthcare SA (“Helsinn”), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, today announced that the...